Physician profile
Alexander Gomelsky
NPI 1730105818
$6,870.39
in general payments reported to CMS, 2019-2025
22 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,346 · 2020: $293 · 2021: $375 · 2022: $1,333 · 2023: $1,352 · 2024: $972 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,638 · Travel and Lodging: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,637.96 |
| Travel and Lodging | $885.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,883.86 | 2021-2025 | Altaviva, Interstim |
| Cook Medical LLC | $839.81 | 2019-2024 | Fiber Dust, Cook |
| Coloplast Corp | $598.64 | 2021-2024 | Titan |
| Boston Scientific Corporation | $530.44 | 2019-2024 | Solyx Sis System |
| Rochester Medical Corporation | $458.42 | 2019-2022 | |
| Pfizer INC. | $380.72 | 2019-2021 | |
| Axonics, INC. | $327.29 | 2023 | Axonics, Bulkamid |
| C. R. Bard, INC. & Subsidiaries | $278.34 | 2019-2023 | Bard Urinary Drainage Bag |
| Intuitive Surgical, INC. | $238.32 | 2022-2024 | |
| Medtronic USA, INC. | $207.16 | 2019 | |
| Profound Medical Corp. | $204.54 | 2022 | |
| Caldera Medical, INC | $162.72 | 2022-2023 | Desara |
| Abbvie INC. | $156.41 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $125.37 | 2019-2023 | Xiaflex |
| Laborie Medical Technologies Corp. | $121.02 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $116.72 | 2021-2022 | |
| Tolmar, INC. | $72.33 | 2023 | |
| Sumitomo Pharma America, INC. | $67.28 | 2023 | Gemtesa |
| Allergan, INC. | $41.96 | 2019-2020 | |
| Genzyme Corporation | $23.55 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $18.55 | 2021 | |
| Kci USA, INC. | $16.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gomelsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.